Cite
miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators
MLA
Vergani, E., et al. MiR-146a-5p Impairs Melanoma Resistance to Kinase Inhibitors by Targeting COX2 and Regulating NFkB-Mediated Inflammatory Mediators. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1308936231&authtype=sso&custid=ns315887.
APA
Vergani, E., Dugo, M., Cossa, M., Frigerio, S., Di Guardo, L., Gallino, G., Mattavelli, I., Vergani, B., Lalli, L., Tamborini, E., Valeri, B., Gargiuli, C., Shahaj, E., Ferrarini, M., Ferrero, E., Gomez Lira, M., Huber, V., Vecchio, M., Sensi, M., … Vallacchi V. (2020). miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators.
Chicago
Vergani, E, M Dugo, M Cossa, S Frigerio, L Di Guardo, G Gallino, I Mattavelli, et al. 2020. “MiR-146a-5p Impairs Melanoma Resistance to Kinase Inhibitors by Targeting COX2 and Regulating NFkB-Mediated Inflammatory Mediators.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1308936231&authtype=sso&custid=ns315887.